ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Johnson & Johnson Pharmaceutical Research and Development, L.L.C.


Include trials that are no longer recruiting patients.

42 studies were found.
1.Recruiting3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
Condition: Schizophrenia
2.CompletedA 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects with Major Depressive Disorder
Condition: Major Depressive Disorder
3.TerminatedA Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery
Conditions: Stomach Neoplasms; Rectal Neoplasms
4.RecruitingEffectiveness and Safety of Risperdal CONSTA in Frequently Relapsing Bipolar Patients
Condition: Bipolar Disorder
5.RecruitingThe Efficacy and Safety of Risperidone in the Treatment of Adolescents with Schizophrenia
Condition: Schizophrenia
6.CompletedEfficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease
Condition: Dementia, Alzheimer Type
7.RecruitingEfficacy and Tolerability of ELMIRON
Condition: Interstitial Cystitis
8.RecruitingET-743 in Men with Advanced Prostate Cancer
Condition: Prostate Cancer
9.RecruitingExtended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
Condition: Schizophrenia
10.CompletedIntramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects with Schizophrenia
Condition: Schizophrenia
11.Not yet recruitingInvestigate Risperidone for the Treatment of Schizophrenia in Adolescents
Condition: Schizophrenia
12.RecruitingLevofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
Condition: Otitis Media
13.TerminatedLong-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers with Regranex or Placebo
Condition: Diabetic Foot Ulcers
14.CompletedOpen label trial exploring a switch from oral medications, to risperidone depot microspheres
Condition: Schizophrenia
15.CompletedPediatric Community-Acquired Pneumonia
Condition: Pneumonia
16.No longer recruitingPhase 2 study of ET-743 in persistent or recurrent endometrial carcinoma
Condition: Endometrial Neoplasms
17.No longer recruitingA Phase 2 study of ET-743 in subjects with advanced breast cancer
Condition: Breast Neoplasms
18.CompletedPhase 2 study of ET-743 in subjects with advanced ovarian cancer
Condition: Ovarian Cancer
19.No longer recruitingPhase 2 Study of ZARNESTRA™ as Postconsolidation Therapy for Acute Myeloid Leukemia in Subjects 60 Years & Older
Condition: Acute Myeloid Leukemia
20.CompletedA Placebo Controlled Trial to evaluate the safety and efficacy of Galantamine in the treatment of vascular dementia
Condition: Dementia, Vascular
21.RecruitingResearch Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)
Condition: Anemia
22.CompletedSafety and efficacy of an anti-psychotic in subjects with schizophrenia
Condition: Schizophrenia
23.CompletedSafety and efficacy of study drug versus placebo for negative symptoms of schizophrenia
Condition: Schizophrenia
24.RecruitingSafety Study with OROS Paliperidone in Geriatric Subjects with Schizophrenia
Condition: Schizophrenia
25.CompletedShort Course Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) (750 mg)
Condition: Bronchitis, Chronic
26.RecruitingA Study of Docetaxel Monotherapy or DOXIL®/CAELYX® and Docetaxel in patients with Advanced Breast Cancer
Condition: Cancer of Breast
27.RecruitingA Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
Conditions: Liposarcoma; Leiomyosarcoma
28.RecruitingStudy of Extended Release OROS® Paliperidone in the prevention of recurrence in subjects with schizophrenia
Condition: Schizophrenia
29.RecruitingA Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
Condition: Schizophrenia
30.No longer recruitingStudy of Letrozole plus ZARNESTRA or Placebo in the Treatment of Advanced Breast Cancer
Condition: Breast Cancer
31.CompletedStudy of Levofloxacin to Evaluate Bacteriologic Outcome In Children with Difficult To Treat Acute Otitis Media
Condition: Otitis Media
32.CompletedA Study of the Safety and Efficacy of Topiramate in the Treatment of Patients with Bipolar I Disorder
Condition: Bipolar Disorder
33.CompletedA Study of the Safety and Efficacy of Topiramate in the Treatment of Patients with Bipolar I Disorder
Condition: Bipolar Disorder
34.No longer recruitingStudy of ZARNESTRA(tm) in Subjects with High-risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
35.RecruitingStudy to determine the effectiveness of risperidone in bipolar disorder in children and adolescents
Condition: Bipolar Disorder
36.TerminatedA study to evaluate the safety and effectiveness of topiramate compared to placebo in the treatment of Bipolar I Disorder.
Condition: Bipolar Disorder
37.RecruitingTipifarnib versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Myeloid Leukemia; Acute Disease
38.TerminatedTreatment of Anemia in Patients with Cancer who Are Not Currently Receiving Chemotherapy or Radiotherapy
Condition: Anemia
39.TerminatedTreatment of Anemic Patients with Cancer who are not Receiving Chemotherapy or Radiotherapy
Conditions: Anemia; Cancer
40.CompletedTreatment Resistant Depression Study
Conditions: Depression; Major Depressive Disorder
41.RecruitingTrial Evaluating the Safety and Efficacy of 2 Doses of ER OROS Paliperidone in Acute Adult Schizophrenics
Condition: Schizophrenia
42.RecruitingTrial of an Anti-HIV-1 Gene Transfer Product
Condition: HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act